D
Crescita Therapeutics Inc. CTX.TO
TSX
Recommendation
Sell
Prev Close
$0.55
Volume
--
Avg Vol (90D)
13,615
Market Cap
$7.33M
Dividend & Yield
--
52-Week Range
$0.36 - $0.69
P/E (TTM)
--
EPS (TTM)
-$0.1068
My Lists My Alerts
Weiss Ratings CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating D
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Excellent
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta -0.56
Price History CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return 0.00%
30-Day Total Return -3.45%
60-Day Total Return 1.82%
90-Day Total Return -6.67%
Year to Date Total Return -5.08%
1-Year Total Return 43.59%
2-Year Total Return -21.13%
3-Year Total Return -11.11%
5-Year Total Return -34.12%
52-Week High % Change -20.29%
52-Week Low % Change 52.78%
Price CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price $0.69
52-Week Low Price $0.36
52-Week Low Price (Date) Mar 14, 2024
52-Week High Price (Date) Jul 22, 2024
Valuation CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 7.33M
Enterprise Value 2.11M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.11
Earnings Per Share Growth 335.92%
Price/Earnings To Growth --
Price/Sales (TTM) 0.83
Price/Book (Q) 0.89
Enterprise Value/Revenue (TTM) 0.16
Price $0.56
Enterprise Value/EBITDA (TTM) -1.61
Enterprise Value/EBIT -0.94
Market Cap Category Nano Cap
Dividends and Shares CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 19.27M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number 800 361 0352
Address 2805 Place Louis-R Renaud Laval, QC H7V 0A3
Website www.crescitatherapeutics.com
Country Canada
Year Founded 2016
Profitability CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) -17.55%
Profit Margin -15.70%
Management Effectiveness CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets -7.90%
Return on Equity --
Income Statement CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) 12.80M
Total Revenue (TTM) 12.80M
Revenue Per Share $0.66
Gross Profit (TTM) 7.11M
EBITDA (TTM) -1.31M
EBIT (TTM) -2.25M
Net Income (TTM) -2.01M
Net Income Avl. to Common (TTM) -2.01M
Total Revenue Growth (Q YOY) 16.54%
Earnings Growth (Q YOY) 20.53%
EPS Diluted (TTM) -0.11
EPS Diluted Growth (Q YOY) 15.99%
Balance Sheet CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 6.25M
Cash Per Share (Q) $0.32
Total Current Assets (Q) 12.05M
Total Preferred Equity (Q) --
Total Equity (Q) 11.89M
Current Ratio (Q) 2.698
Book Value Per Share (Q) $0.62
Total Assets (Q) 16.79M
Total Current Liabilities (Q) 4.47M
Total Debt (Q) 685.40K
Total Liabilities (Q) 4.90M
Total Common Equity (Q) 11.89M
Cash Flow CTX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) -1.30M
Cash from Financing (TTM) -646.50K
Net Change in Cash (TTM) -1.16M
Levered Free Cash Flow (TTM) -405.30K
Cash from Operations (TTM) 799.20K
Weiss Ratings